The clinical characteristics of childhood-onset and late-onset functional seizures: How do they differ?

Ali A Asadi-Pooya1, Murli Mishra2, Mohsen Farazdaghi3

  • 1Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.

PubMed

Insights

Late-onset functional seizures (FS) are linked to more medical issues and head injuries. Childhood-onset FS often goes undiagnosed for years, highlighting the diverse nature of this neurological condition.

Area of Science:

  • Neurology
  • Epilepsy Research
  • Clinical Neuroscience

Background:

  • Functional seizures (FS) are a neurological disorder with varying onset ages.
  • Investigating differences between childhood-onset and late-onset FS is crucial for understanding disease heterogeneity.
  • Previous research has not fully elucidated the distinct characteristics of these two FS subtypes.

Purpose of the Study:

  • To compare the clinical characteristics and predisposing factors of childhood-onset functional seizures (FS) versus late-onset FS.
  • To identify potential age-associated differences in the presentation and progression of FS.
  • To provide evidence supporting FS as a heterogeneous condition.

Main Methods:

  • A retrospective study comparing patients with FS onset at age 14 or younger versus age 50 or older.
  • Data collected from epilepsy monitoring units at centers in Iran and the USA.
  • Inclusion of 140 patients: 80 with childhood-onset FS and 60 with late-onset FS.

Main Results:

  • Late-onset FS patients had significantly higher rates of medical comorbidities (OR=13.9) and head injury history (OR=5.97).
  • The duration of illness was considerably longer in childhood-onset FS (6 years) compared to late-onset FS (2 years).
  • Similarities and differences in clinical features and risk factors were identified between the two groups.

Conclusions:

  • Functional seizures represent a heterogeneous condition with distinct features based on age of onset.
  • Late-onset FS is associated with a higher burden of comorbidities and a history of head trauma.
  • Childhood-onset FS is prone to prolonged periods of being undiagnosed and untreated, underscoring the need for timely diagnosis.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
436
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
217
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
350
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
91
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
122
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
208